Alzheimer's disease is traditionally regarded as neurodegenerative disease, an illness that results in progressive neuronal damage due to protein accumulation.
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.
Adult survivors of pediatric Hodgkin lymphoma have accelerated epigenetic aging, and many have evidence of neurocognitive decline on standardized testing.
Deakin and Barwon Health partner in new centre for disease research miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The addition of first-line brentuximab vedotin to chemotherapy reduced risk for relapse compared with standard treatment among pediatric patients with high-risk Hodgkin lymphoma, according to study results. The findings, published in The New England Journal of Medicine, additionally showed the brentuximab vedotin (Adcetris, Seagen) regimen to be well tolerated.